Endometriosis Triggers Excessive Activation of Primordial Follicles via PI3K-PTEN-Akt-Foxo3 Pathway.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 03 02 2019
accepted: 14 06 2019
pubmed: 21 6 2019
medline: 4 6 2020
entrez: 21 6 2019
Statut: ppublish

Résumé

The ovarian reserve is reduced in patients with endometriosis. We hypothesize that the phosphatidylinositol 3-kinase (PI3K)-phosphatase and tensin homolog deleted on chromosome 10 (PTEN) Akt-Forkhead box O (Foxo3) pathway is involved in reducing the ovarian reserve. To elucidate the signaling mechanism by which endometriosis decreases ovarian reserve. Studies were conducted by using a mouse model for endometriosis and human ovaries. The endometriosis mouse model was established and ammonium trichloro (dioxoethylene-o,o') tellurate (AS101), an inhibitor of PI3K-PTEN-Akt pathway, was administered to experimental mice. Human ovaries were collected during surgery from patients with endometrioma or from patients with no ovarian pathology (control ovaries). The number of follicles and expression of Foxo3, PTEN, phosphorylated mammalian target of rapamycin and phosphorylated Akt by oocytes in primordial follicles in mouse and human ovaries were detected by immunohistochemical staining and evaluated. In the endometriosis mouse model, the proportion of primordial follicles was diminished, and the proportion of primary, secondary, antral, and growing follicles was increased in comparison with controls. In both mouse and human ovaries, the PI3K-PTEN-Akt-Foxo3 pathway was activated in samples from endometriosis. Administration of AS101 restored the proportion of primordial follicles in endometriotic mice ovaries to control levels. The current study describes the excessive activation of primordial follicles and the role of the PI3K-PTEN-Akt-Foxo3 pathway in the reduction of ovarian reserve associated with endometriosis. Our results suggest that a PI3K-PTEN-Akt inhibitor should be considered for further investigation as promising medicines for the prevention of the ovarian reserve reduction in patients with endometriosis.

Identifiants

pubmed: 31219551
pii: 5520383
doi: 10.1210/jc.2019-00281
doi:

Substances chimiques

Forkhead Box Protein O3 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1
PTEN Phosphohydrolase EC 3.1.3.67

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5547-5554

Informations de copyright

Copyright © 2019 Endocrine Society.

Auteurs

Arisa Takeuchi (A)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Kaori Koga (K)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Erina Satake (E)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Tomoko Makabe (T)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Ayumi Taguchi (A)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Mariko Miyashita (M)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Masashi Takamura (M)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Miyuki Harada (M)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Tetsuya Hirata (T)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Yasushi Hirota (Y)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Osamu Yoshino (O)

Obstetrics and Gynecology, Kitasato University School of Medicine, Kitasato, Minami-ku, Sagamihara-shi, Kanagawa, Japan.

Osamu Wada-Hiraike (O)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Tomoyuki Fujii (T)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Yutaka Osuga (Y)

Obstetrics and Gynecology, University of Tokyo, Hongo Bunkyo Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH